Retraction Note: Targeting KDM4A-AS1 represses AR/AR-Vs deubiquitination and enhances enzalutamide response in CRPC

Detalles Bibliográficos
Autores principales: Zhang, Boya, Zhang, Mingpeng, Yang, Yanjie, Li, Qi, Yu, Jianpeng, Zhu, Shimiao, Niu, Yuanjie, Shang, Zhiqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Retraction Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473956/
https://www.ncbi.nlm.nih.gov/pubmed/37524853
http://dx.doi.org/10.1038/s41388-023-02790-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473956/
https://www.ncbi.nlm.nih.gov/pubmed/37524853
http://dx.doi.org/10.1038/s41388-023-02790-8

Ejemplares similares